VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.300
-0.012 (-3.76%)
Dec 5, 2025, 4:00 PM EST - Market closed
VolitionRx Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for VolitionRx stock have an average target of 3.17, with a low estimate of 1.50 and a high estimate of 5.00. The average target predicts an increase of 957.72% from the current stock price of 0.30.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VolitionRx stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,568.34% | Dec 4, 2025 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 3, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,568.34% | Nov 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2.5 → $1.5 | Strong Buy | Maintains | $2.5 → $1.5 | +400.50% | Nov 17, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +1,568.34% | Nov 17, 2025 |
Financial Forecast
Revenue This Year
1.92M
from 1.23M
Increased by 55.33%
Revenue Next Year
11.38M
from 1.92M
Increased by 493.79%
EPS This Year
-0.22
from -0.31
EPS Next Year
-0.11
from -0.22
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.3M | 30.7M | ||||
| Avg | 1.9M | 11.4M | ||||
| Low | 1.5M | 2.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 82.9% | 1,503.7% | ||||
| Avg | 55.3% | 493.8% | ||||
| Low | 19.2% | 42.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.21 | 0.09 | ||||
| Avg | -0.22 | -0.11 | ||||
| Low | -0.25 | -0.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.